个性化眼科服务推进您的眼科治疗
Strong connections with Patient Advocacy Groups: trials designed with patients in mind.
Experience in working with ophthalmology sites to improve efficiency and protocol compliance.
Relationships with specialized vendors for ocular services: the right tools for your trial.
在决策时将患者的需求放在首位并确保您的眼科研究成功方面，经验至关重要。在过去的五年中，我们为新兴和中型生物技术公司提供了灵活的解决方案，Fortrea的专业知识和见解帮助推进了超过110项临床眼科研究。
过去5年来
We’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers in the advancement of their ophthalmology therapies and supported:
114
Ophthalmology Studies
1,993
研究中心
12,616
患者
Anterior Indications such as:
Posterior Indications such as:
我们分享我们的最新动态、活动和出版物。
From working on over 100 ophthalmology studies in just the last 5 years alone, we understand the importance of a personalized approach to the unique challenges of ophthalmology including cell & gene therapies. We're setting our teams up for success so they can successfully deliver life changing trials for patients with vision loss.
-Tanya Richardson, Executive Director & Global Lead, Strategic Delivery & Growth, Ophthalmology, Fortrea
Fortrea的整体方法是针对每种眼病适应症定制策略，借助与研究中心建立的关系，为每项研究寻找最具实力、高绩效的研究中心，并利用现有协议加速启动。我们的专属主题专家团队提供全面的、以数据为导向的研究中心和患者参与策略，其中包括从以前和当前的眼科试验中获得的最佳实践。
一旦您的试验开始，您可以依靠Fortrea的眼科临床试验管理团队提供密切的沟通和协作。我们致力于找到进行视敏度评估和对眼部成像进行集中读取的认证服务提供商。 We also use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.
Fortrea has the tools to help improve health and lives by bringing vision treatments to market quickly and carefully.
